Company Encyclopedia
View More
name
Senseonics
SENS.US
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company’s products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.
1.407 T
SENS.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking74/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-209.12%E
    • Profit Margin-217.65%E
    • Gross Margin42.84%B
  • Growth ScoreA
    • Revenue YoY31.94%A
    • Net Profit YoY20.62%B
    • Total Assets YoY45.25%A
    • Net Assets YoY281.76%A
  • Cash ScoreC
    • Cash Flow Margin-45.95%D
    • OCF YoY31.94%A
  • Operating ScoreD
    • Turnover0.25D
  • Debt ScoreC
    • Gearing Ratio44.14%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Sio Capital Management LLC Purchases New Stake in Senseonics Holdings, Inc. $SENS

    Sio Capital Management LLC acquired 4,852,298 shares of Senseonics Holdings, Inc. in Q2, valued at $2,312,000, making it 0.9% of their holdings. Other hedge funds also adjusted their positions in Senseonics. Insider purchases were made by CFO Frederick T. Sullivan and Director Edelman Steven. Analysts have given the stock a consensus 'Buy' rating with a target price of $22.70. Senseonics focuses on continuous glucose monitoring systems for diabetes.

    Market Beat·
    US
    SENS
    -1.63%
    Market Beat·
    US
    SENS
    -1.63%

    COO Jain Surrenders 10,317 Of Senseonics Holdings Inc [SENS]

    Jain Mukul, COO of Senseonics Holdings Inc, surrendered 10,317 shares back to the company to cover option exercise costs and/or tax liabilities. This transaction was filed with the SEC on November 18, 2025. The shares were valued at $64,584, with an ending holding of 259,979 shares directly. The Washington Service provides insider trading analysis and data services.

    Reuters·
    US
    SENS
    -1.63%
    Reuters·
    US
    SENS
    -1.63%

    Director Steven Edelman Acquires Common Shares of Senseonics Holdings Inc

    Steven Edelman, a director at Senseonics Holdings Inc., has acquired common shares of the company. This event was reported through EDGAR by the U.S. Securities and Exchange Commission on November 13, 2025. The acquisition is a significant corporate event.

    Reuters·
    US
    SENS
    -1.63%
    Reuters·
    US
    SENS
    -1.63%

    Senseonics Unveils Strategy to Accelerate Growth With One-Year CGM System

    Senseonics Holdings Inc. has unveiled its strategy to accelerate growth in the global continuous glucose monitoring (CGM) market, projected to reach $13.5 billion by 2025. The company is promoting its Eversense 365 system, the first one-year CGM, while addressing patient concerns like sensor longevity and accuracy. Their roadmap includes increasing awareness, expanding market access, and enhancing user experience through targeted marketing and optimized commercial capacity. Senseonics aims to drive revenue growth in this underpenetrated market.

    Reuters·
    US
    SENS
    -1.63%
    Reuters·
    US
    SENS
    -1.63%

    Insider Moves: Top Executives Shake Up Senseonics Holdings Stock!

    Recent insider activity at Senseonics Holdings (SENS) includes significant transactions by executives, with Director Douglas Roeder purchasing 15,000 shares and CEO Timothy T. Goodnow selling 17,210 shares. The company reported a 90% year-over-year revenue growth but faces financial challenges, leading Mizuho to lower its price target while H.C. Wainwright raised theirs. Despite a positive outlook from strategic initiatives, Spark's AI Analyst rates SENS as Neutral due to high leverage and cash flow issues, with a current market cap of $245.6M and a year-to-date price performance of -42.60%.

    Tip Ranks·
    US
    SENS
    -1.63%
    Tip Ranks·
    US
    SENS
    -1.63%
    © 2025 Longbridge｜Disclaimer